• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,243.34 -116.67
( -0.16%)
Global Indices
Nasdaq
51,098.17 -484.76
(-0.94%)
Dow Jones
7,440.28 -165.03
(-2.17%)
Hang Seng
66,711.59 -759.10
(-1.13%)
Nikkei 225
10,374.30 13.98
(0.13%)
Forex
USD-INR
95.73 0.01
(0.01%)
EUR-INR
111.21 0.07
(0.06%)
GBP-INR
128.58 -0.06
(-0.05%)
JPY-INR
0.60 0.00
(0.01%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

colorchips varcas solutions ltd
Alembic Pharmaceuticals consolidated net profit rises 29.20% in the March 2026 quarter
May 15,2026
Net profit of Alembic Pharmaceuticals rose 29.20% to Rs 202.70 crore in the quarter ended March 2026 as against Rs 156.89 crore during the previous quarter ended March 2025. Sales rose 4.41% to Rs 1847.72 crore in the quarter ended March 2026 as against Rs 1769.64 crore during the previous quarter ended March 2025.

For the full year,net profit rose 15.66% to Rs 674.77 crore in the year ended March 2026 as against Rs 583.42 crore during the previous year ended March 2025. Sales rose 10.08% to Rs 7344.90 crore in the year ended March 2026 as against Rs 6672.08 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1847.721769.64 4 7344.906672.08 10
OPM %12.3415.33 -15.2315.11 -
PBDT231.97260.93 -11 1079.49972.89 11
PBT143.38191.94 -25 760.94694.31 10
NP202.70156.89 29 674.77583.42 16